Volume 18, Issue 1, Pages (July 2013)

Slides:



Advertisements
Similar presentations
Figure 1 Body weight of control and BPA-treated mothers after delivery
Advertisements

Volume 19, Issue 1, Pages (January 2014)
Volume 14, Issue 6, Pages (December 2011)
Volume 14, Issue 2, Pages (August 2011)
Volume 9, Issue 3, Pages (March 2009)
Volume 14, Issue 4, Pages (October 2011)
Volume 126, Issue 3, Pages (March 2004)
Volume 3, Issue 1, Pages (July 2002)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 8, Issue 4, Pages (October 2008)
Volume 17, Issue 3, Pages (March 2013)
Volume 16, Issue 10, Pages (September 2016)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 10, Issue 4, Pages (October 2009)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 22, Issue 1, Pages (July 2015)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 6, Issue 3, Pages (September 2007)
Volume 18, Issue 2, Pages (August 2013)
Volume 6, Issue 3, Pages (September 2007)
Volume 15, Issue 2, Pages (February 2012)
Volume 19, Issue 4, Pages (April 2014)
Volume 21, Issue 11, Pages (December 2017)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 5, Issue 2, Pages (February 2007)
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 17, Issue 5, Pages (May 2013)
Volume 15, Issue 5, Pages (May 2012)
Volume 8, Issue 4, Pages (August 2014)
Volume 19, Issue 6, Pages (June 2014)
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Volume 25, Issue 6, Pages e8 (June 2017)
Volume 7, Issue 2, Pages (February 2008)
Volume 20, Issue 1, Pages (July 2014)
Volume 9, Issue 3, Pages (March 2009)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 16, Issue 7, Pages (August 2016)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 12, Issue 3, Pages (September 2010)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 23, Issue 6, Pages (June 2016)
Volume 16, Issue 4, Pages (October 2012)
Volume 6, Issue 4, Pages (October 2007)
Volume 10, Issue 5, Pages (November 2009)
Volume 10, Issue 1, Pages (July 2009)
Volume 14, Issue 1, Pages (July 2011)
Volume 5, Issue 5, Pages (May 2007)
Volume 1, Issue 4, Pages (April 2005)
Volume 24, Issue 8, Pages e7 (August 2018)
Volume 22, Issue 2, Pages (August 2015)
Volume 6, Issue 1, Pages (July 2007)
Volume 6, Issue 3, Pages (September 2007)
Volume 14, Issue 4, Pages (October 2011)
Volume 17, Issue 3, Pages (March 2013)
Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis  Sarah H. Bates, Rohit N. Kulkarni, Matthew.
Prevention of Steatosis by Hepatic JNK1
Volume 8, Issue 5, Pages (November 2008)
Volume 14, Issue 2, Pages (August 2011)
Volume 7, Issue 6, Pages (June 2008)
Volume 22, Issue 2, Pages (August 2015)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 6, Issue 4, Pages (October 2007)
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
Volume 18, Issue 1, Pages (July 2013)
Volume 24, Issue 6, Pages (December 2016)
Volume 26, Issue 2, Pages e3 (January 2019)
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Volume 16, Issue 3, Pages (September 2012)
Presentation transcript:

Volume 18, Issue 1, Pages 106-117 (July 2013) Reciprocal Regulation of Hepatic and Adipose Lipogenesis by Liver X Receptors in Obesity and Insulin Resistance  Simon W. Beaven, Aleksey Matveyenko, Kevin Wroblewski, Lily Chao, Damien Wilpitz, Tu Wen Hsu, Jacob Lentz, Brian Drew, Andrea L. Hevener, Peter Tontonoz  Cell Metabolism  Volume 18, Issue 1, Pages 106-117 (July 2013) DOI: 10.1016/j.cmet.2013.04.021 Copyright © 2013 Elsevier Inc. Terms and Conditions

Cell Metabolism 2013 18, 106-117DOI: (10.1016/j.cmet.2013.04.021) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Characterization of LOKO Mice (A) WT, DKO, OB, and LOKO mice were weighed weekly. n = 10–11 WT or DKO; n = 20–33 OB or LOKO. No significant weight differences between OB and LOKO mice were observed. (B) Size comparison of lean (WT) and obese (OB and LOKO) mice. (C) At 24 weeks of age, mice were fasted for 12 hr, euthanized, and organs were harvested. Liver and WAT weights are shown normalized to total body weight (n = 19 OB, 17 LOKO). Values are means ± SEM. (D) Indirect calorimetry was performed on mice between 14 and 18 weeks of age. Mice were acclimatized to cages for 6+ hr, and data were then collected for an additional 72 hr (n = 7 OB, 8 LOKO). (E) Pooled plasma from OB and LOKO mice (n = 5–8) was analyzed by FPLC. Statistical analysis was by two-way ANOVA with Bonferroni post hoc tests (A and E) or Student’s t test (C and D): ∗∗p < 0.01; ∗∗∗p < 0.001; N.S., not significant. Cell Metabolism 2013 18, 106-117DOI: (10.1016/j.cmet.2013.04.021) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 LOKO Livers Are Rescued from Hepatic Steatosis (A) Markers of hepatocellular necrosis (AST and ALT) were measured by colorimetric assay in WT, DKO, OB, and LOKO mice (n = 6–8 mice per group). (B) LOKO livers are smaller and lack significant steatosis by gross examination. (C) Representative H&E sections from OB and LOKO mice are shown. Magnification = 100×. (D) Hepatic lipids were extracted and quantified from WT, DKO, OB, and LOKO mice (n = 5–6 mice per group). (E) Hepatic gene expression was measured in WT, DKO, OB, and LOKO mice (n = 5–9 mice per group) at 24 weeks of age. Results are first normalized to expression of the housekeeping gene 36B4 and shown as fold induction over WT animals. Values are means ± SEM. Statistical analysis was by one-way ANOVA with Bonferroni post hoc tests: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; N.S., not significant. Cell Metabolism 2013 18, 106-117DOI: (10.1016/j.cmet.2013.04.021) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 LOKO Mice Are Glucose Intolerant but Insulin Sensitive (A) Borderline fasting hyperglycemia and insulinopenia in LOKO mice. Mice were fasted overnight, glucose was measured by glucometer, and insulin was measured by multiplexed bead assay (Luminex, Millipore) (n = 5 per group). (B) Random blood glucose levels from a separate group of OB and LOKO mice, showing significant hyperglycemia. Similar results were obtained in three separate experiments. Glycosuria in LOKO mice is shown by chemical reaction with clinical urine test strips. (C) GTTs were performed by i.p. injection of 1 mg/kg glucose into OB and LOKO mice (n = 5 per group) fasted for 6 hr. Time-course measurements of blood glucose and insulin from the same experiment are shown. Values are means ± SEM. This experiment was repeated three times in two different cohorts of mice. (D) LOKO mice are highly insulin sensitive in response to exogenous insulin. A separate cohort of OB (n = 15) and LOKO (n = 8) mice was analyzed by the hyperinsulinemic-euglycemic clamp technique as described in the Experimental Procedures. Values are expressed as means ± SEM. (E) Western blotting for hepatic Akt and its phosphorylated form (pSer473) showing increased basal pAkt expression in LOKO mice. Blotting was performed on whole livers from individual animals (n = 3) of each genotype (OB and LOKO) under three conditions: (1) fasting for 6 hr (Fast), (2) fasting for 6 hr with a single i.p. injection of insulin (12 U/kg) administered 30 min before sacrifice (Ins 30’), and (3) at the end of hyperinsulinemic-euglycemic clamps from Figure 3D (Clamp). A single representative blot is shown. Band density was quantified by image analysis and expressed relative to the fasted OB animals. (F) Quantification of total β cell mass from pancreatic sections stained for insulin production (n = 10–15 mice per genotype). Additional sections were immunofluorescently stained for insulin and a proliferative marker, Ki-67, and hand counted for cell numbers (n = 10−11 for each genotype; n = 277,990 individual β cells tabulated across all genotypes). The average number of β cells and proliferating (Ki-67+) β cells for each genotype are shown. (G) Pancreatic islets were isolated from obese mice as described in the Experimental Procedures for glucose-stimulated insulin perifusion studies. After overnight recovery, islets were exposed to a low basal level of glucose (4 mM) for 40 min and then switched into high-glucose media (16 mM) for another 40 min. Samples of the perfusate were measured for islet-secreted insulin by ELISA (n = 3 separate channels per time point). Statistical analysis was by Student’s t test (A, B, D, and F) or two-way ANOVA with Bonferroni post hoc tests (C and G): ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Cell Metabolism 2013 18, 106-117DOI: (10.1016/j.cmet.2013.04.021) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Activation of the Adipose PPARγ Pathway in LOKO Mice (A) H&E staining and gross morphology of epididymal fat pads from OB and LOKO mice. Magnification = 100×. (B) Exon gene array profiling (Affymetrix) was performed on pooled RNA from WT, DKO, OB, and LOKO mice (n = 5–8 mice per group). Global gene expression was filtered for genes showing at least a 2-fold change. Red demonstrates increased expression, whereas blue shows genes with decreased expression. (C) Real-time quantitative gene-expression validation from WAT. (D) Isotope-labeled glucose uptake in isolated fat pads from obese mice as described in the Experimental Procedures. (E–G) ChREBP pathway gene expression (E), inflammatory gene expression (F), and insulin-stimulated gene expression (G) from WAT in lean, obese, and obese mice injected i.p. with a single dose of insulin (12 U/kg) 30 min before sacrifice (“+ Ins”). Values are means ± SEM. Statistical analysis was by Student’s t test (C–F) or one-way ANOVA (G) with Bonferroni post hoc tests: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Cell Metabolism 2013 18, 106-117DOI: (10.1016/j.cmet.2013.04.021) Copyright © 2013 Elsevier Inc. Terms and Conditions